Combination therapy of trandolapril and candesartan cilexetil reduces microalbuminuria and urinary endothelin-1 excretion in patients with type 2 diabetes.

Nakamura T, Ushiyama C, Osada S, Takahashi Y, Shimada N, Ebihara I, Koide H

Open source

DOI
10.1007/s101570200023
Published
2002 Sep
Container
Clinical and experimental nephrology
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s101570200023,
  title = {Combination therapy of trandolapril and candesartan cilexetil reduces microalbuminuria and urinary endothelin-1 excretion in patients with type 2 diabetes.},
  author = {Nakamura T and Ushiyama C and Osada S and Takahashi Y and Shimada N and Ebihara I and Koide H},
  year = {2002},
  journal = {Clinical and experimental nephrology},
  doi = {10.1007/s101570200023},
  url = {https://doi.org/10.1007/s101570200023}
}

RIS

TY  - JOUR
TI  - Combination therapy of trandolapril and candesartan cilexetil reduces microalbuminuria and urinary endothelin-1 excretion in patients with type 2 diabetes.
AU  - Nakamura T
AU  - Ushiyama C
AU  - Osada S
AU  - Takahashi Y
AU  - Shimada N
AU  - Ebihara I
AU  - Koide H
PY  - 2002
JO  - Clinical and experimental nephrology
DO  - 10.1007/s101570200023
UR  - https://doi.org/10.1007/s101570200023
ER  - 

APA

T, N., C, U., S, O., Y, T., N, S., I, E., & H, K. (2002). Combination therapy of trandolapril and candesartan cilexetil reduces microalbuminuria and urinary endothelin-1 excretion in patients with type 2 diabetes.. Clinical and experimental nephrology. https://doi.org/10.1007/s101570200023

Source records